About Us

“Neuregenix was founded in 2007 by Professor Martin Berry, Dr Zubair Ahmed and myself, three neuroscientists focussed on neurotrauma, with an ambition to enhance the impact of our own area of research excellence. The last 5 years have confirmed and expanded that ambition.

As a niche CRO working in the neurological and ophthalmology research arenas, we now work with a team of world class experimental and clinical research scientists and opinion leaders to provide a range of drug discovery, preclinical drug screening and clinical trial services to the biotechnology and pharmaceutical industry worldwide.

The direct links forged between our scientists and our customers are the guarantee of a fruitful working relationship, reinforced by our recognised expertise, high staff motivation and quality of delivery.”

Professor Ann Logan BSc PhD

website by whitespace